Displaying items 2721-2722 of 2722 in total
The medtech giant projects robust growth with an ambitious pipeline, but a high-stakes regulatory showdown over a key acquisition could redefine its future.
Promising survival data and a novel biomarker strategy from BriaCell could reshape the metastatic breast cancer treatment and investment landscape.
Get your daily brief delivered to your inbox every morning at 7am
